Shea, P. R., Sanyal, A., Harrison, S., Ratziu, V., Loomba, R., Caldwell, S., … Goldstein, D. B. (2016). PNPLA3 Variants Confer an Increased Risk of Advanced Fibrosis Due to Non-Alcoholic Steatohepatitis. In Journal of Hepatology (Vol. 64, pp. S493–S493). Elsevier BV. https://doi.org/10.1016/s0168-8278(16)00846-1

Shea, P. R., A. Sanyal, S. Harrison, V. Ratziu, R. Loomba, S. Caldwell, A. M. Diehl, et al. “PNPLA3 Variants Confer an Increased Risk of Advanced Fibrosis Due to Non-Alcoholic Steatohepatitis.” In Journal of Hepatology, 64:S493–S493. Elsevier BV, 2016. https://doi.org/10.1016/s0168-8278(16)00846-1.

Shea PR, Sanyal A, Harrison S, Ratziu V, Loomba R, Caldwell S, et al. PNPLA3 Variants Confer an Increased Risk of Advanced Fibrosis Due to Non-Alcoholic Steatohepatitis. In: Journal of Hepatology. Elsevier BV; 2016. p. S493–S493.

Shea, P. R., et al. “PNPLA3 Variants Confer an Increased Risk of Advanced Fibrosis Due to Non-Alcoholic Steatohepatitis.” Journal of Hepatology, vol. 64, no. 2, Elsevier BV, 2016, pp. S493–S493. Crossref, doi:10.1016/s0168-8278(16)00846-1.

Shea PR, Sanyal A, Harrison S, Ratziu V, Loomba R, Caldwell S, Diehl AM, Kleinstein SE, Myers RP, Mani Subramanian G, McHutchison JG, Abdelmalek MF, Bosch J, Afdhal N, Goldstein DB. PNPLA3 Variants Confer an Increased Risk of Advanced Fibrosis Due to Non-Alcoholic Steatohepatitis. Journal of Hepatology. Elsevier BV; 2016. p. S493–S493.